• Profile
Close

Outcomes of onabotulinum toxin A treatment for adductor spasmodic dysphonia and laryngeal tremor

JAMA Otolaryngology—Head & Neck Surgery Feb 13, 2018

Patel PN, et al. - The outcomes of onabotulinum toxin A treatment on adductor spasmodic dysphonia (ADSD), ADSD + lateral laryngeal tremor (LT), and lateral LT without ADSD were comparatively evaluated during this study. Data unveiled that the administration of onabotulinum toxin A injections into the thyroarytenoid/lateral cricoarytenoid muscle complex was an effective treatment for ADSD, ADSD+LT, and LT without ADSD. Nonetheless, among patients with ADSD, greatest effectiveness was observed. To prognosticate the effectiveness of onabotulinum toxin A injection among patients presenting with tremor components, defining tremor directionality could prove to be useful.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay